General MedicationsINJECTIONGeneric

ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID

Standard Dose

3MG/1ML

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: None (Tentative Approval)

Summary

Approval overview ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID is listed in Drugs@FDA under application 219632 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID Form and strength INJECTION - 3MG/1ML Sponsor GLAND PHARMA LIMITED Submission history Latest submission status date: 2025-06-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID is listed in Drugs@FDA under application 219632 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID Form and strength INJECTION - 3MG/1ML Sponsor GLAND PHARMA LIMITED Submission history Latest submission status date: 2025-06-25 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.